Trial Profile
A phase 1 trial of ACAM 529 for herpes simplex virus infections
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 11 Oct 2012
Price :
$35
*
At a glance
- Drugs SP 0148 (Primary)
- Indications Herpes simplex virus infections
- Focus Adverse reactions
- 11 Oct 2012 New trial record